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younger age, and lower midarm circumference, and increasedInterdialytic weight gain and survival in hemodialysis patients:
Kt/V, PCR, and serum potassium concentration. The meanEffects of duration of ESRD and diabetes mellitus.
follow-up period was 48.9 6 10.6 months. An increase in IWGBackground. Medical mortality determinants in end-stage
was associated with a significantly increased relative mortalityrenal disease (ESRD) patients treated with hemodialysis (HD)
risk in diabetic ESRD patients treated with HD when variationsare well known. More recently, associations have been estab-
in age, comorbidity, serum albumin concentration, and dialyzerlished between the dose of dialysis administered and patient
type and site were controlled. There was, however, no associa-survival. We showed in a prospective study that both dialyzer
tion of increased mortality risk with increased IWG in thetype and patient compliance with the dialysis prescription were
larger population of patients without diabetes. In further analy-independently associated with survival. Although several pa-
ses, the increased mortality risk associated with increased IWGrameters of dialytic technique and patient compliance are asso-
ciated with differential survival in patients with ESRD treated was found to be present only in patients with diabetes mellitus
with HD, the association of interdialytic weight gain (IWG) who had recently started HD therapy for ESRD.
with survival is unclear. No study has assessed the relationship Conclusion. IWG is correlated with several nutritional and
between IWG and mortality in HD patients, controlled for dialytic variables and with parameters that predict survival in
multiple medical risk factors. The aim of our study was to HD patients. Increased IWG is independently associated with
determine whether IWG was associated with survival in pa- decreased survival of diabetic ESRD patients treated with HD,
tients with ESRD treated with HD, controlling for multiple after adjusting for variation in other medical risk factors. The
medical and dialytic risk factors. population of incident diabetic HD patients is particularly sus-
Methods. We prospectively conducted an observational, ceptible to increased risk associated with increased IWG. The
longitudinal, multicenter study of 283 urban HD patients to mechanisms underlying these results are obscure, but IWG
determine the relationship of IWG with several dialytic param- might be associated with poorer survival in this population if
eters and patient survival. Medical risk factors such as demo- it were linked to worsened hypertension, cardiovascular stress,
graphic indices and comorbid conditions were assessed. We or poorer glycemic control. Interventions to improve compli-
studied Kt/V, the protein catabolic rate (PCR), serum albumin ance with IWG in incident diabetic HD patients are warranted.
and anthropometric measurements, behavioral compliance in-
dices, dialyzer characteristics, and serum electrolyte concentra-
tions, and correlated these with IWG. In addition, the duration
Compliance of HD patients is multifactorial and de-of dialysis was assessed in HD patients with and without diabe-
tes mellitus. Cox proportional hazards models assessed the pends in large part on its defining parameters. To date,
relative mortality risk of increased IWG, controlling for varia- investigators in this field have not been able to agree on
tions in medical comorbidity and other mortality determinants.
an index to serve as a gold standard for its measurementResults. The mean (6SD) age of our population was 54.6 6
[1]. Compliance in this population depends on the extent14.1 years, and the mean time they were treated with HD was
30.4 6 46.9 months. The mean IWG was 1.54 6 0.71% dry wt/ to which an individual’s behavior corresponds with the
day. Correlations were found between increased IWG and medical team’s advice regarding dietary restrictions,
medication regimens, and dialysis schedules [1]. As such,
it can be measured by both subjective and objectiveKey words: weight gain, ESRD, chronic renal disease, survival on
hemodialysis, anthropometry. indices, but compliance is difficult to assess with certainty
[1–7]. Behavioral compliance has been associated withReceived for publication April 26, 1999
survival [7, 8], but the mediators of the effect have beenand in revised form September 7, 1999
Accepted for publication September 17, 1999 poorly understood [2, 8]. We recently established quanti-
tative measures to assess the effect of patients’ shorten-Ó 2000 by the International Society of Nephrology
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ing and skipping treatments, compared with physicians’ the Washington Veterans Affairs Medical Center Dial-
ysis Unit (VAMC), all in Washington D.C, with theprescribed times, and showed that these were often unre-
lated to standard biochemical compliance measures used exception of HIV-infected patients, patients who had a
psychiatric diagnosis of psychosis, and patients who failedto evaluate HD patients [2, 3, 8, 9]. Few studies have
assessed the relationship between behavioral compliance a minimental status exam, were eligible for the study. The
follow-up ended December 31, 1997. Written informedmeasures and other factors, but older patients and Cau-
casian patients in several U.S. studies exhibited im- consent was obtained at GWUMC and HUMC. Verbal
consent was obtained prior to patients’ enrollment atproved behavioral compliance [1, 3].
Because of the complexity of this parameter, several the VAMC. The study was approved by the institutional
review boards of the three medical centers. Details re-other factors besides the behavioral measurements pre-
viously mentioned have been considered as HD compli- garding our recruitment procedures have been previously
reported [3]. Two hundred eighty-three patients had se-ance markers, such as interdialytic weight gain (IWG),
serum phosphate and potassium concentrations, pa- rial measurements of IWG and continuous determina-
tions of updated dry weight. In our recruitment planning,tient’s protein ingestion measured by protein catabolic
rate (PCR), and adequacy of dialysis treatment. Unfortu- incident patients were defined as those who had com-
menced renal replacement therapy with HD less thannately, each of these variables may be influenced by
factors unrelated to compliance with prescribed medical six months at the time of study entry [9]. Prevalent pa-
tients were defined as those who had commenced renaland dietary regimens. Residual renal function, dialytic
technique, drugs, and interactions among them can all replacement therapy with HD for more than six months
at the time of study entry [8]. The demographics of ouraffect their measurements [2, 3, 9].
Interdialytic weight gain is considered another mea- patient population are shown in Table 1.
surement of compliance because it may be dictated, at
Measuresleast in part, by patient behavior. The role of IWG in
determining survival is unclear. A recent study reported Medical risk factors. Disease severity was determined
by the ESRD severity coefficient of Plough et al, whichthat HD patients who had greater than a 5.7% interses-
sion IWG had a 35% higher risk of death, greater than the was previously validated in a large sample of ESRD pa-
tients [17] and in our earlier studies [8]. The product ofrisk of death for skipping or shortening HD sessions [7].
The medical determinants of mortality in patients with the patients’ age and the relative risk (RR) of additional
medical illness, such as cardiovascular and cerebrovascu-end-stage renal disease (ESRD) treated with hemodialy-
sis (HD) have been well delineated, consisting of demo- lar disease, diabetes mellitus, collagen vascular disease,
and malignancy, was used to derive the coefficient [8, 17],graphic factors, the presence of diabetes mellitus, serum
albumin levels, dose of dialysis administered, and comor- an overall measure of the level of severity of the patient’s
renal and comorbid chronic illnesses. In order to assessbid conditions [8, 10–17]. Most of these factors have also
been associated with IWG [1, 3, 18–20]. It has been the possible effects of residual renal function on survival,
the duration of ESRD therapy was used as a surrogate,unclear whether deleterious effects of IWG are associ-
ated with the presence of diabetes mellitus in this popula- as previous studies have shown that the glomerular fil-
tration rate decreases as the course of therapy with HDtion [21, 22].
To determine whether IWG was associated with sur- continues [23].
Nutritional and anthropometric variables. PCR andvival in patients with ESRD treated with HD, we pro-
spectively examined the predictive power of IWG to the mean of three sequential monthly predialysis serum
albumin, potassium, and phosphate concentrations afterpredict mortality, after controlling for multiple medical
and dialytic risk factors in patients with ESRD treated enrollment were determined. The midarm circumference
(MAC) and arm muscle area (AMA) measurements werewith HD, with and without diabetes mellitus.
obtained by trained personnel at study entry, as pre-
viously described [3, 8, 9, 24, 25]. The percentage of ideal
METHODS
weight was calculated according to reference standards
Patient population and demographics obtained from healthy adults during the National Health
and Nutrition Examination Surveys (NHANES II), pre-We prospectively conducted an observational, longitu-
dinal multicenter study of urban HD patients. Patient viously used in HD populations [26].
recruitment, limited to three HD centers in Washington,
Dialytic parametersD.C., began September 1, 1992, and concluded April 1,
1996. All of the patients enrolled in chronic ESRD HD Interdialytic weight gain was calculated as the patients’
weight at the beginning of each HD session (preweight)programs at the George Washington University Medical
Center’s Ambulatory Dialysis Unit (GWUMC), Howard minus the weight after (postweight) the previous HD
session, divided by the nephrologists’ determined dryUniversity Medical Center’s Dialysis Unit (HUMC), and
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Table 1. Demographics of the hemodialysis (HD) patients studied
Total population Patients with DM Patients without DM
(N 5 283) (N 5 119) (N 5 164)
Age years 54.6614.1 59.0611.3 51.4614.9b
Range 19–84 26–84 19–83
Gender
Male 71.4% (N 5 202) 73.9% (N 5 88) 69.5% (N 5 114)
Female 28.6% (N 5 81) 26.1% (N 5 31) 30.5% (N 5 50)
Race
African American 91.9% (N 5 260) 96.6% (N 5 115) 88.4% (N 5 145)a
White and others 8.1% (N 5 23) 3.4% (N 5 4) 11.6% (N 5 19)
Incident patients 39.9% (N 5 113) 43.7% (N 5 52) 37.2% (N 5 61)
Prevalent patients 60.1% (N 5 170) 56.3% (N 5 67) 62.8% (N 5 103)
All values are expressed as mean 6 SD or percent. DM is diabetes mellitus.
aP 5 0.003, bP 5 0.0001, patients with and without diabetes mellitus
weight, divided by the interdialytic period in days, ex- Individual behavioral compliance measures are highly
stable over time [3, 8].pressed as the percentage of change per day (%/d). IWG
was calculated on the basis of the average of all measure-
Statistical methodsments over a three-month period, beginning with the
date of study entry. The value for dry weight was continu- All of the behavioral compliance data displayed highly
ously updated according to nephrologists’ changes in positively skewed distributions. Correlations between
orders throughout the study. demographic data, medical risk factors, nutritional and
Kt/V was assessed monthly at GWUMC and HUMC anthropometric variables, dialytic parameters, and com-
and quarterly at VAMC using the percentage of urea pliance factors were assessed by Pearson’s correlation
reduction (URR), as outlined by Jindal, Manuel, and coefficients or Spearman’s rank order correlation coeffi-
Goldstein [3, 8, 9, 27]. The dialyzer used in each patient’s cients, in the cases of skewed distribution of data, as pre-
treatment at study entry was noted and categorized as viously described [3, 8, 9]. Differences between groups
unmodified cellulose, modified cellulose, or synthetic ac- were assessed by unpaired t-tests, the Wilcoxon test, chi-
cording to the scheme of Hakim et al [8, 16]. square analysis, and analysis of variance (ANOVA), as
Behavioral compliance. Behavioral compliance indi- appropriate [3, 8, 9].
ces were collected for three months after the study entry. Survival time for each patient was determined both
by the number of days between date of initial studyIndividual rates of shortening, skipping, and integrated
total time compliance were calculated. Patients’ behav- evaluation and the end of the study observation period
or date of death, and the number of days from the startioral compliance with their prescribed HD regimen was
assessed as previously described [3, 8, 9]: (1) The percent of ESRD therapy to the end of the study observation
period or the patient’s death. In addition, analyses weretime compliance (%TCOMP) consisted of the amount
of time the patient was actually dialyzed compared with conducted evaluating survival from 90 days after the
study entry until the end of the study observation periodthe time physicians prescribed, only for sessions attended
by the patient. This quantifies the time patients may or date of death. Survival status was confirmed using the
Health Care Finance Administration database, obtaineddecrease the length of dialysis sessions, characterizing
“shortening” behavior. (2) The percent attendance through ESRD Network 5 (Richmond, VA, USA) for all
patients enrolled in the study. Cox proportional hazards(%ATTEND) comprised the number of sessions at-
tended compared with the number prescribed, quantitat- regression was used to predict mortality hazard [28].
Following the results of initial bivariate Cox regressionsing the percentage of sessions from which the patient
was absent without excuse (such as being hospitalized with selected demographic and dialytic indices [8], re-
gression analyses were performed in the whole HD pop-or receiving treatment as a transient patient in another
unit), characterizing “skipping” behavior. (3) The total ulation, in the groups of diabetic and nondiabetic HD
patients, in incident and prevalent populations, and intime of compliance (%TTC) reflects the fraction of time
the patient received dialysis compared with the total time incident and prevalent populations with and without dia-
betes mellitus. The relationship between IWG and sur-prescribed in both attended and unattended sessions.
This is an overall measure of compliance with the dialysis vival was examined in these groups while simultaneously
controlling for predictor medical risk factors (patients’prescription, including “skipping” and “shortening” be-
haviors. The resulting values were averaged over a three- age, severity coefficient, level of serum albumin concen-
tration, dialyzer type, and dialysis site) [8]. To determinemonth period, beginning with the date of study entry.
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whether there was a nonlinear relationship between sur-
vival and IWG, both IWG and patients’ predialysis
weights were stratified into quartiles, and regressions
were performed in each of these subgroups. RRs or
hazards, as outlined in text and tables, represent the
expected change in mortality risk associated with a 1%
increase in IWG. Analyses were performed using PROC
PHREG in SAS 6.12 (SAS Institute Inc., Cary NC, USA)
using the exact method for ties. The a level of tests
of survival and group differences was 0.05. Data are
presented as mean 6 SD.
RESULTS
Population description
The total enrolled sample surveyed who had baseline
assessment of dialytic and behavioral compliance mea-
sures and IWG comprised 283 subjects. African Ameri-
cans comprised 91.9% (N 5 260) of our patient popula-
tion (Table 1). Eighty-one (28.6%) of the patients were
female, and 119 (42%) had diabetes mellitus (Table 1).
One hundred thirteen (39.9%) of the patients were inci-
dent to ESRD, and 170 (60.1%) were prevalent. Forty-
six percent of the incident and 39.4% of the prevalent
patients had diabetes mellitus (data not shown). There
was no difference between the proportions of incident
and prevalent patients with diabetes.
The mean age of our patient population was 54.6 6
14.1 years (Table 1). Patients had been treated with HD
for mean and median times of 30.4 6 46.9 and 12.7
months, respectively, at the time of study enrollment
(Table 2). The patients’ mean serum albumin concentra-
tion was 3.8 6 0.49 g/dL. The patients’ mean predialysis
weight was 73.9 6 17.5 kg (data not shown). In the 210
patients (74.2%) in whom the percentage of ideal weight
was assessed, the mean value was 102.1 6 22.8%. An-
thropometric evaluations were performed in 237 of the
subjects (83.7%). Anthropometry could not be per-
formed in 46 subjects because of disability associated
with cerebrovascular disease, refusals, transfers from the
unit, or death before assessment. The mean MAC and
AMA were 25.8 6 4.2 cm and 545.6 6 182.1 mm2, respec-
tively. These findings suggest the patients had compara-
ble nutritional status to a normative cohort of patients
with ESRD treated with HD [26]. The patients’ baseline
mean PCR was 1.06 6 0.27 g/kg/day. The mean URR
was 0.60 6 0.092 (data not shown), and the mean Kt/V
was 1.2 6 0.4. These values are comparable to those
delineated in the ESRD Core Indicator Project, monitor-
ing U.S. ESRD HD patients from the period of 1992
through 1995, when URRs ranged from 0.63 6 0.097
to 0.64 6 0.089 (personal communication, Drs. Pamela
Frederick and Diane Frankenfield, Health Care Financ-
ing Administration, Baltimore, MD, USA), and the
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mean Kt/V demonstrated in special studies by the
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Table 3. Correlation matrix of variables with IWG in ESRD
patients treated with HD with and without DM
Total population Patients with Patients without
(N 5 283) DM (N 5 119) DM (N 5 164)
r P r P r P
Age 20.16 0.004 20.24 0.009 20.108 0.16
Gender 20.01 0.89 0.08 0.38 20.07 0.37
Race 20.06 0.29 20.09 0.29 20.04 0.64
Serum albumin 20.11 0.06 20.1 0.28 20.14 0.07
PCR 0.25 0.0001 0.22 0.02 0.26 0.001
Kt/V 0.19 0.002 0.24 0.01 0.14 0.08
%IW 20.24 0.0004 20.09 0.44 20.31 0.0005
MAC 20.13 0.05 20.23 0.02 20.07 0.43
AMA 20.11 0.08 20.21 0.04 20.06 0.49
Serum K 0.21 0.0003 0.18 0.38 0.22 0.006
Serum P 0.07 0.25 0.076 0.41 0.06 0.47
%TCOMP a 20.13 0.02 20.19 0.04 20.09 0.25
%ATTENDa 0.05 0.36 0.02 0.79 0.08 0.29
%TTCa 20.05 0.37 20.06 0.47 20.03 0.72
Abbreviations are: IWG, interdialytic weight gain; %IW, percentage of ideal
weight; PCR, protein catabolic rate; MAC, mean arm circumference; AMA, arm
muscle area; K, potassium; P, phosphate; DM, diabetes mellitus; %TCOMP,
percent time compliance; %ATTEND, percent attendance; %TTC, total time
compliance (see text for details).
aSpearman correlation; all other correlations are Pearson correlation coeffi-
cients
Fig. 1. Distribution of mean interdialytic weight gain (IWG) in 283
stable patients with end-stage renal disease (ESRD) treated with hemo-
cellulose dialyzers (1.63 6 0.73% dry weight/day, P 5dialysis (HD). IWG was calculated as the patients’ weight after each HD
session, divided by determined dry weight, divided by the interdialytic 0.01; data not shown). There was no significant associa-
period in days, expressed as a percentage of change per day (%/day). tion of IWG and patient gender. There was no differenceIWG was calculated on the basis of the average of all measurements
in mean IWG between patients with and without diabe-over a three-month period, during which dry weight was continuously
updated from physicians orders. tes mellitus, or between men and women, or between
African Americans and patients of other ethnic back-
grounds (data not shown).
Increased IWG was associated with younger patient
USRDS for 1993 was 1.1 (personal communication, Dr.
age (r 5 20.16, P 5 0.004) and higher Kt/V and PCR
L. Agodoa, NIDDK, NIH, Bethesda, MD, USA). Forty- (r 5 0.19, P 5 0.002, and r 5 0.25, P 5 0.0001, respec-
three of the patients were treated with unmodified cellu- tively; Table 3). IWG inversely correlated with patients’
lose, 12.6% with modified cellulose, and 44.4% with syn- predialysis weight (r 5 20.24, P 5 0.0003; data not
thetic dialyzers. shown). IWG inversely correlated with MAC (r 5 20.13,
Behavioral compliance data were available for all of P 5 0.05) and with the percentage of ideal weight (r 5
the patients. %TCOMP was 97.8 6 2.8%, with a range 20.24, P 5 0.0004), but not with AMA (r 5 20.11, P 5
of 86.3 to 100%. The mean %ATTEND was 98.4 6 0.08). IWG correlated with mean serum potassium con-
5.7%, with a range of 38.8 to 100%, and the mean %TTC centration (r 5 0.21, P 5 0.0003), but not with mean
was 96.1 6 6.6%, with a range of 36.4 to 100%. These serum phosphate concentration (r 5 0.07, P 5 0.25). The
averages are comparable to those previously reported correlation between increased IWG and lower serum
by others [29, 30]. albumin concentration approached but did not reach a
The patients’ mean predialysis serum potassium con- level of statistical significance (r 5 20.11, P 5 0.06).
centration was 4.8 6 0.8 mEq/L, and the mean predialysis Increased IWG was inversely correlated with worsened
serum phosphate concentration was 5.6 6 1.7 mg/dL. shortening behavior (r 5 20.13, P 5 0.02, Spearman
test), but there was no correlation of patients’ IWG and
Interdialytic weight gain level of attendance, total integrated time compliance
The mean IWG was 1.54 6 0.71% dry weight/day (Table 3), or dialyzer type used in treatment (data not
(Table 2) (range 0.23 to 4.61%). Distribution of IWG shown).
showed a moderate skew (1.04; Fig. 1). The median value
Associations with duration of end-stageof IWG was 1.44% dry weight/day, and 90% of the values
renal disease therapywere lower than 2.57% dry weight/day (Fig. 1). The mean
IWG was lower in patients treated with synthetic (1.42 6 There was no difference in the mean age or severity
coefficient between incident and prevalent patients (data0.67% dry weight/day) compared with those treated with
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not shown). Incident patients were treated with HD for cantly lower mean serum albumin concentrations and
Kt/V compared with incident non-diabetic patients, buta mean of 2.1 6 1.3 months at the time of study entry,
compared with 49.6 6 52.7 months for prevalent patients there were no differences between the two groups in
the mean percentage ideal weight, IWG, PCR, serum(P , 0.0001; Table 2). In prevalent patients, IWG corre-
lated inversely with patients’ predialysis weight (r 5 phosphate or potassium concentration, or anthropomet-
ric indices (data not shown). Prevalent diabetic patients20.24, P 5 0.0035), but there was no significant correla-
tion of the variables in incident patients (r 5 20.18, P 5 were older and had a higher mean percentage of ideal
weight and MAC than prevalent non-diabetic patients,0.12), perhaps in part because of the smaller number
of subjects (data not shown). There was a significant but there were no differences between the two groups
in mean IWG, PCR or Kt/V, serum albumin, phosphatecorrelation between IWG and the number of days the
patient had been treated for ESRD with HD at the time or potassium concentrations, or AMA (data not shown).
There were a few differences between significant cor-of study entry (r 5 20.165, P 5 0.0045; data not shown).
There were, however, no correlations of IWG and dura- relations in patients with and without diabetes compared
with the population as a whole. In patients with diabetestion of HD therapy for ESRD prior to study entry in
incident patients (r 5 20.074, P 5 0.44), prevalent pa- mellitus, there was no correlation of percentage ideal
weight or serum potassium concentration with IWG. Thetients (r 5 0.055, P 5 0.48), prevalent patients without
diabetes mellitus (r 5 0.0077, P 5 0.44), prevalent pa- correlation between IWG and patients’ predialysis weight
approached the level of statistical significance in patientstients with diabetes mellitus (r 5 20.0077, P 5 0.54),
incident patients without diabetes mellitus (r 5 20.10, with diabetes (r 5 20.20, P 5 0.06), but it was significant
in the population without diabetes (r 5 20.25, P 5 0.0035;P 5 0.43), and incident patients with diabetes mellitus
(r 5 20.03, P 5 0.81; data not shown). data not shown). In patients without diabetes mellitus,
no correlations between IWG and age, Kt/V, MAC,As in previous interim analyses in this patient popula-
tion [9], incident patients had significantly lower mean AMA, or shortening behavior were found (Table 3).
There was no correlation between IWG and patients’Kt/V, PCR and serum albumin, potassium, and phos-
phate concentrations compared with prevalent patients predialysis weight (r 5 20.12, P 5 0.48) in the small
group of incident patients with diabetes (data not shown).(Table 2). Incident patients had a significantly lower IWG
than prevalent patients (1.31 6 0.65 vs. 1.70 6 0.71% dry
Survival analyseswt/day, P 5 0.0001). There was no difference between
the mean levels of anthropometric indices of incident The mean follow-up time was 48.9 6 10.6 months
(range 20.9 to 60.5 months). A Cox regression applied toand prevalent patients.
There were similar statistically significant correlations the entire sample confirmed, as expected, a significantly
increased mortality risk for each decade increase in age,between IWG and age, Kt/V and PCR, MAC and serum
potassium concentration in the prevalent patient popula- each unit increase in severity coefficient, and each de-
crease in serum albumin concentration, as previouslytion (compared with the whole patient population of 283
patients outlined in Table 3; data not shown). In contrast described [8].
Finally, the effects of variation in IWG were tested.to the whole population, there was no correlation of
IWG and duration of dialysis, serum phosphate concen- Patients’ age, severity coefficient, level of serum albumin
concentration, and dialyzer type and site were enteredtration, or shortening behavior in the prevalent patients
(data not shown). There were no similar statistically sig- in the Cox regression first and thus controlled for prior
to analysis. In the whole HD population, an increase innificant correlations between IWG and other demo-
graphic, biochemical, or compliance measures in the inci- IWG was not associated with a significant increase in
RR, when variations in age, severity of illness, serumdent patients, with the exception of the correlation of
IWG and serum albumin concentration (r 5 20.32, P 5 albumin concentration, and dialyzer type and site were
controlled (RR 1.24, P 5 0.14; Table 4). In the nondia-0.0007; data not shown).
betic HD patients, increased IWG was also not associ-
Associations with diabetes mellitus ated with an increased RR after controlling for the pre-
viously mentioned factors (RR 0.913, P 5 0.65). In HDThere was no significant association between the pres-
ence of diabetes mellitus and changes in IWG. The only patients with diabetes mellitus, there was, however, a
significant association between increased IWG and mor-differences between patients with and without diabetes
mellitus were that patients with diabetes were treated tality. For each 1% increase in IWG, there was a 67.5%
increase in relative mortality risk, after controlling forfor ESRD for a shorter period of time at the study entry,
they had lower mean serum potassium concentrations, other factors (RR 1.675, P 5 0.01; Table 4). There was
no significant increase in relative mortality risk associ-and they had a higher percentage ideal body weight
(Table 2). ated with increased IWG in incident or prevalent sub-
populations (Table 4). While there was no increasedIncident diabetic patients were older and had signifi-
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Table 4. Survival analysis: Predicting mortality by Cox regression analysis, using IWG in different ESRD populations,
after controlling for medical risk factors
Population N RR 95% CI P
ESRD HD population 283 1.24 0.93–1.64 0.14
ESRD HD patients without DM 164 0.913 0.61–1.36 0.65
ESRD HD patients with DM 119 1.675 1.12–2.51 0.01
ESRD incident HD patients 113 1.39 0.82–2.36 0.23
ESRD incident HD patients with DM 52 2.9 1.14–7.4 0.025
ESRD incident HD patients without DM 61 0.77 0.325–1.82 0.55
ESRD prevalent HD patients 170 0.9 0.62–1.32 0.59
ESRD prevalent HD patients with DM 67 1.15 0.68–1.95 0.61
ESRD prevalent HD patients without DM 103 0.672 0.40–1.13 0.13
Abbreviations are: IWG, interdialytic weight gain; ESRD, end-stage renal disease; HD, hemodialysis; DM, diabetes mellitus; RR, risk ratio; CI, confidence interval.
RRs refer to 1% increase per dry weight per day (details are in the text).
relative mortality risk associated with increased IWG in haviorally related factors affecting IWG [9]. The mean
prevalent patients with diabetes mellitus, there was a duration of ESRD therapy at the time of enrollment in
190% increase in relative mortality risk in the subset of our patient population was 30 months, and it is therefore
incident patients with diabetes mellitus (RR 2.90, CI 1.14 unlikely that the majority of patients maintained a sub-
to 7.4, P 5 0.025). Similar findings were noted when Cox stantial urine output at this point. Since studies have
analyses were performed in the subset of incident pa- demonstrated that residual renal function in HD patients
tients with diabetes mellitus, assessing patient survival decreases as duration of ESRD therapy increases [23],
from the start of ESRD therapy with HD (RR 3.05, CI we used both their duration of HD and epidemiologic
1.19 to 7.8, P 5 0.021). There were no differences in status as surrogates for this parameter. Because of our
interpretation of findings when survival analyses started sampling strategies, there was a marked difference be-
at the end of the three-month initial data collection period. tween the duration of ESRD therapy in incident and
In the whole HD population and in the subset of dia- prevalent patients (2 months vs. 4 years). It is similarly
betic HD patients, an association of increased mortality unlikely that there was clinically significant residual renal
risk with predialysis weight or IWG could not be demon- function in the prevalent subgroup in this study. Al-
strated when stratification of these variables was used though there were lower levels of serum albumin concen-
in Cox regression equations (data not shown). tration, Kt/V and PCR in incident compared with preva-
lent patients, demographic risk factors such as age, race,
extent of comorbidity, and anthropometric indices wereDISCUSSION
not different between the two groups. In accord with thisSeveral different lines of evidence suggest that compli-
strategy, lower levels of serum phosphate and potassiumance with dietary and medical regimens [7, 8, 12] of
concentration, as well as IWG in the incident population,patients with ESRD treated with HD is associated with
may reflect differences between residual renal functionoutcomes, such as survival. However, compliance is
in these two subpopulations. Unfortunately, this parame-clearly a multifactorial concept that involves at least sev-
ter was not directly measured in our study.eral types of behavior: adherence to several different
Different studies have defined IWG and the level oftypes of fluid and dietary restrictions, medication regi-
IWG defined as noncompliant in various ways. Kaplanmens, and treatment schedules [1, 2, 9]. The complexity
de Nour, in her multifaceted five-point scale, consideredof the dimensions of compliance, the lack of a clear gold
absolute values of IWG ranging from 0.5 kg to greaterstandard for its measurement, and the multiple factors
or equal to 2.5 kg [5]. Manley and Sweeney consideredinvolved in determining the survival of the HD popula-
three measures of weight gain: absolute weight gain, thetion also make it difficult to assess. Among the multiple
standard deviation of each patient’s weight gain, and themeasurements that have been used to estimate the com-
ratio of weight gain to dry weight [6]. Agashua et alpliance of HD patients, we used objective parameters
used the presession weight and two cut-off points (meansuch as IWG and quantitated measures of patients’ short-
intersession weight gain of 1 and 1.5 kg, clinically de-ening and skipping behaviors, and integrated total be-
termining the upper limits of dietary compliance) [31].havioral compliance, and analyzed their interrelations
Leggat et al using the USRDS database defined noncom-with HD survival risk factors.
pliance as greater than 5.7% of dry weight per interdia-Interdialytic weight gain is primarily determined by
lytic session [7]. It is not clear in the latter study whetherthe HD patients’ fluid and sodium ingestion, but factors
data were normalized for sessions separated by a variablesuch as hyperglycemia and hyperosmolality, residual re-
nal function, and extent of urine output may be nonbe- number of days. The wide variation among the different
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methods used to define the compliant values of IWG study, however, there was no correlation of IWG and
patient gender. Similar results were reported by Leggatmeasurements and the lack of clear association with out-
come measures have made it difficult to generalize when et al [7]. The discrepancy between the finding of a corre-
lation between gender and behavioral compliance in ourrating patients’ compliance on this factor. In our study,
we used a more accurate method to measure IWG. A earlier study and the lack of such an association in the
present study may be due to the fact that the earlierpercentage of IWG per day, accounting for the variability
in interdialytic days between three-times weekly sessions study [3] was smaller and limited to only prevalent pa-
tients who had survived at least six months of dialyticover each month, was calculated using the average of
measurements during a three-month period, with the therapy for ESRD.
The mean values of serum albumin concentration, PCR,nephrologists’ dry weight continuously updated. This
may be particularly important in incident patients, in and anthropometric measurements in our sample suggest
that we studied a well-nourished population of HD pa-whom dry weight may change during the early part of
treatment, but may increase during later months of ther- tients [26]. In our patients, we found that IWG was corre-
lated with PCR, and the inverse correlation betweenapy, as recently outlined [32]. We correlated our continu-
ous value of IWG with different parameters without IWG and serum albumin concentration approached the
level of statistical significance. These results are compa-considering a distinct cut-off. Only slightly more than
10% of our patients had an IWG comparable to that rable to those found by other investigators. Testa and
Beaud recently showed a positive correlation betweenused as a mortality marker by Leggat et al [7]. This
may account for some of the discrepancy between our IWG and PCR and serum albumin levels in 38 patients
with ESRD treated with HD [20]. The group of patientsfindings. In addition, this group assessed a prevalent pop-
ulation, perhaps also accounting for some of the discrep- with higher levels of mean IWG had a higher mean
serum albumin concentration. In the same study, ageancies in risk assessments between the two studies.
To assess patient’s behavioral compliance, we used a was negatively correlated with both IWG and PCR, and
the authors concluded that IWG was associated withthree-month period to determine a score based on a
scale that characterized “shortening” and “skipping” be- better nutritional status. Sherman et al reported, in a
large number of ESRD patients, that greater IWG ishaviors and an overall measure of compliance with the
dialysis prescription, including “skipping” and “shorten- associated with a higher normalized PCR and showed a
trend towards a positive correlation between levels ofing” behaviors. We showed in previous reports that indi-
vidual behavior compliance measures of patients’ short- IWG and serum albumin [18]. They had, however, pre-
viously hypothesized an inverse relationship betweenening, skipping, and integrated total time compliance
are highly stable over time [3]. When correlating these these two variables (as found in the present study). They
suggested the lack of significance (or an inverse correla-variables with IWG, we found that shortening behavior
was inversely correlated with IWG, but there was no cor- tion) might have been a function of dilution of predialysis
serum albumin concentrations by increased total bodyrelation between IWG and the level of attendance or
total integrated time compliance. These results may be water, as a result of noncompliance with fluid restric-
tions. We agree with this interpretation.explained by the dependence of IWG on fluid removal
scheduled during a particular HD procedure (in effect To our knowledge, no other studies have investigated
the association of IWG and other parameters of nutri-predicating that shortening treatments leads to lower
achieved ultrafiltration rates). In contrast, patients who tional status, such as anthropometric measurements. We
analyzed these variables and found that IWG was in-skip sessions may voluntarily restrict interdialytic fluid
intake. versely correlated with MAC and with the percentage
of ideal weight. No correlation was found between IWGAge has been a consistently strong predictor of compli-
ance in many studies in ESRD patients [3, 7, 9, 31, 33, 34]. and AMA. These results do not support a robust associa-
tion of IWG and nutritional status. The findings may beWe and others have shown that younger patients are
more likely to be noncompliant, whereas older patients because anthropometric measurements are not suffi-
ciently precise or may be misleading in patients withare more likely to be compliant [2, 3, 7, 8]. In this study,
we found that increased IWG was associated with ESRD because of altered tissue hydration or myopathy.
We recently reported preliminary findings showing thatyounger patient age, supporting the usefulness and gen-
eralizability of our measure of IWG as a compliance serum albumin concentration is a better prognostic
marker than anthropometric measures in HD patientsbehavior. This association, however, suggests that all
analyses of the relationship between IWG and mortality [35]. Other more sophisticated measures of body compo-
sition, such as bioelectrical impedance analysis, dual-must be controlled for age.
In a previous report, we showed that men were signifi- energy x-ray absorptiometry, and total body nitrogen have
been used as methods of nutritional assessment [36, 37],cantly more likely to be noncompliant, as measured by
skipping or shortening HD sessions [3]. In the current but their relationship to survival remains unknown in
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HD patients. However, as with compliance measures, We observed a correlation of IWG with age, as others
have. In addition, the correlation of IWG and serumno gold standard exists for the nutritional evaluation of
patients with ESRD treated with HD. albumin approached the level of statistical significance.
IWG in our study was correlated with dialytic markersWe found, as expected, that IWG was positively corre-
lated with Kt/V and with the mean serum potassium that have been found to be associated with survival in
epidemiologic studies, such as Kt/V. IWG was correlatedconcentration, but not with the mean serum phosphate
concentration. Sherman et al found that Kt/V was higher with a behavioral compliance measure, which we have
previously shown to be associated with enhanced sur-in patients with high IWG as a percentage of dry weight,
but could not demonstrate a significant correlation be- vival [8]. When relative mortality risk associated with
variation in IWG was controlled for variation in age,tween the two variables in a large patient population [18].
Differences between our findings and theirs may be due severity of comorbid illness, serum albumin concentra-
tion, and dialyzer type, we were unable to show an associ-to differences in evaluation of Kt/V. Morduchowicz et al,
in a study of 50 patients, were unable to demonstrate a ation with survival in the whole population. In addition,
there was little relationship between IWG and type ofcorrelation of serum phosphate concentration and IWG
[38]. Predialytic serum ion concentrations may be af- dialyzer used, which we [8] and others [16] have shown is
a parameter associated with differential mortality. Thesefected by multiple variables besides dietary intake, such
as the effects of hemodilution, medications, residual re- findings and our analytic strategy suggest differences in
IWG do not underlie the differential survival of HDnal function, hormonal status, and acid-base homeostasis
[1, 2, 9]. Kt/V and serum potassium concentration have patients treated with different types of dialyzers.
In this study, we show that diabetic ESRD patientsusually been linked with dialytic parameters and not
generally used as compliance markers by themselves treated with HD, who have greater morbidity and mor-
tality than nondiabetic ESRD patients [10], are particu-[2, 7, 12, 15, 16, 31]. In contrast, serum phosphate concen-
tration has been used as a marker of both dietary and larly susceptible to mortality when IWG is increased. Of
note, although there were few differences between themedication compliance, while its predialytic and postdia-
lytic levels are not closely related to dialytic clearance two populations, the diabetic patients were more over-
weight and had a tendency to hypoalbuminemia. Al-[2, 7, 12, 30]. Lowrie and Lew [12] and we (unpublished
data from this population) found that hyperphosphate- though the percentage of the population studied with
diabetes was substantial, no correlation was found be-mia is a mortality risk factor for HD patients. These
findings further emphasize the lack of association we tween the presence of diabetes and IWG. Previous stud-
ies have suggested a relationship between increased IWGcurrently found between IWG and survival in patients
without diabetes mellitus. and poor glycemic control in ESRD patients with diabe-
tes [21] and increased IWG in HD patients with diabetesThe relationship between IWG and type of dialyzer
has not been reported in current studies of this subject. mellitus [21]. The association we found between IWG
and mortality in the diabetic HD population suggestsWhen using high-flux dialyzers, it is possible to remove
large amounts of fluid, which can in turn determine that excessive IWG could be a contributory factor to
progression of cardiovascular disease in patients alreadychanges in patients’ osmolality and body volume that
may affect interdialytic fluid intake. We analyzed pa- at risk [39].
Recent work has shown increased survival in a largelytients’ treatments with unmodified cellulose dialyzers
with low ultrafiltration coefficients and modified cellu- African American population with increased body mass
index [40]. Our measure of IWG was normalized for drylose and synthetic dialyzers with higher ultrafiltration
coefficients [8]. In the present study there was no correla- weight. Although stratification analyses of predialytic
weight and IWD in our relatively small population didtion of patient IWG and dialyzer type used for treatment,
although there was a difference between mean IWG in not reveal associations with increased risk, increased
IWG would be of greatest consequence in those incidentpatients treated with cellulose compared with synthetic
dialyzers. These findings suggest that, although IWG is diabetic patients with the lowest body mass indices.
Alternatively, increased IWG may be associated withaffected by several dialytic factors, the different effects
determined by the type of dialyzer used in HD treatment poor glycemic control, which might also mediate poorer
survival [21], or with any deleterious effects of hyperten-are not intimately associated with variations in IWG.
Such notions must, however, be assessed in carefully sion. A link between level of blood pressure and outcome
in HD patients has not been clearly established [re-planned, multicenter, randomized, prospective controlled
studies. It should be observed that the dialyzer type was viewed in 41, 42]. A recent study in a large population
of U.S. HD patients did not demonstrate an associationcontrolled for in all survival analyses in this study.
It is important to note in any analysis of the association of predialysis hypertension and mortality, and found no
difference between outcomes regarding such parametersof IWG with survival that IWG had been correlated with
several established mortality risk factors in HD patients. in diabetic and nondiabetic patients [41]. In their analy-
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ses, high presumptive IWG was not associated with a sistent with malnutrition, but they were underweight.
Differences in these factors or analytic approaches maylow blood pressure mortality effect. However, control of
blood pressure, often with antihypertensive medications, account for this difference in study results. Moreover,
has been shown to be associated with improved outcomes our findings may not be generalizable beyond an urban,
in European [43] and American patients [reviewed in 41 African American population. Further outcome studies
and 42]. The role of blood pressure or antihypertensive must be performed addressing the association between
therapy [42] in association with outcome was unfortu- IWG, glycemic control, and the incidence and prevalence
nately not assessed in this study. In patients with diabe- of cardiovascular disease in larger populations of African
tes, worsened shortening behavior was associated with American and other diabetic patients with ESRD treated
increased IWG. This may also be a mechanism whereby with HD. This is particularly important because of the
IWG mediates poorer outcome, as well as psychological overrepresentation of African American patients in the
differences between the groups [8]. U.S. ESRD program.
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